Engaged in research and development, production and marketing of active pharmaceutical ingredients and intermediates.
YanTai YuChen Biological Medicine Co. Ltd. is a hi-tech enterprise integrating R&D, production and marketing, and sits at Laiyang, Shandong Province. Our institute boasts a professional R&D team and a production base engaged in research and development, production and marketing of active pharmaceutical ingredients and intermediates.
The company was founded in
At present, China's pharmaceutical intermediate industry has a high degree of marketization. As a whole, it has the characteristics of more small and medium-sized enterprises, concentrated production areas, stable business scale, low technological level, and serious product homogenization. The difficulty of new product development is becoming more and more difficult, and the competition for traditional products is becoming more and more fierce. Coupled with the influence of national environmental protection policies, the market size of the pharmaceutical intermediate industry has declined and grown slowly.In 2018, the market size of China's pharmaceutical intermediates industry was about 201.7 billion yuan, down 24% year-on-year: the industry will return to positive growth in 2020.
Fine chemical industry refers to the industry that produces fine chemicals, commonly known as the fine chemical industry.Products in this industry refer to chemical products with specific application functions, technology-intensive, strong commercial nature, and high product added value.
China's pharmaceutical intermediate industry is an important part of China's pharmaceutical industry and an important force in promoting the development of China's pharmaceutical industry.In recent years, with the development of China's pharmaceutical industry, China's pharmaceutical intermediate industry has also made great strides.